Adam Klein

Office Phone:

+972-3-6089999

Direct Phone:

972-3-607-4421


  Pro - Try 1 Week Free
 

    and access,

  •     75K PE/M&A Contacts
  •     +
  •     4.6K PE Firms
  •     3.6K M&A Advisors
  •     194K Transactions
  •     198K Companies

  •     Market Services
  •     Build Lists
  •     Research Sectors
  •     Uncover Opportunities

Bio

Adam Klein is Vice Head of the International Corporate and Securities Department of the firm, and a member of the Executive Committee. Adv. Klein specializes in cross-border corporate and finance transactions, including mergers and acquisitions, public offerings, SPACs, Rule 144A offerings, tender offers, ‘going private’ transactions, spin-offs, PIPEs, and private equity and venture capital investments. Adv. Klein advises Israeli SEC-registered companies and dual-listed companies on their corporate governance requirements under Israeli law and under the rules of the SEC, NYSE, and NASDAQ. Adv. Klein also advises foreign companies and investment funds on their acquisitions, financings, investments and business activities in Israel. He possesses particular expertise in U.S. public offerings and public offerings of foreign companies on the Tel Aviv Stock Exchange. In recent years, Adv. Klein has advised on some of the largest and most complex merger and acquisition transactions and cross-border public offerings in Israel, in which he has represented multinational corporations and private equity funds in Israeli transactions, as well as Israeli corporations and global investment banks in overseas transactions. Due to his experience in both M&A and U.S. capital markets, Adv. Klein has been involved in multiple de-SPAC transactions, representing the SPAC, the target, lead shareholders, or investors in the SPAC sponsor. Adv. Klein has been recognized as one of Israel’s leading attorneys in the capital markets, corporate and M&A fields by Chambers & Partners and Best Lawyers. Adv. Klein advised the Ethics Committee of the Israel Bar Association on rules of conduct for attorneys under the Sarbanes-Oxley Act; crafted the first U.S.-style Shareholder Rights Plan (‘Poison Pill’) in Israel, which enables public companies to defend themselves from hostile takeovers; and lecturers to professional audiences on a variety of legal topics. From 1992 to 1999, Adv. Klein was an associate in the Corporate and Financial Services Department of Willkie Farr & Gallagher, New York.

Education

Work History

Lathrop GPM LLP